Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Gastroenterology & Hepatology|November 10, 2025
IL-1 family of cytokines in gastrointestinal and liver disordersJulian Schwärzler, Paola Menghini, Charles Dinarello, et al.
The Journal of Infectious Diseases|August 19, 2005
Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shockJessica Jones-Carson, Giamila Fantuzzi, Britta Siegmund, et al.
Human Vaccines & Immunotherapeutics|February 2, 2013
Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activationThomas Aagaard Rasmussen, Ole Schmeltz Søgaard, Christel Brinkmann, et al.
The Journal of Infectious Diseases|September 17, 2008
Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injuryChristopher C Moore, Edward N Martin, Grace Lee, et al.
Molecules (Basel, Switzerland)|July 27, 2022
Human and Bacterial Toll-Interleukin Receptor Domains Exhibit Distinct Dynamic Features and FunctionsEunjeong Lee, Jasmina S Redzic, Travis Nemkov, et al.
Scandinavian Journal of Gastroenterology|July 9, 2008
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver diseaseOthmar Ludwiczek, Edouard Vannier, Alexander Moschen, et al.
Atherosclerosis|November 6, 2016
Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivoSiroon Bekkering, Inge van den Munckhof, Tim Nielen, et al.
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Msphere|February 23, 2018
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory ResponsesChristel Rothe Brinkmann, Jesper Falkesgaard Højen, Thomas Aagaard Rasmussen, et al.
Iscience|November 24, 2025
Interleukin-38 is a negative regulator of trained immunity-A retrospective multi-omics studyLisa U Teufel, Vasiliki Matzaraki, Lukas Folkman, et al.
Pageof 1